List of IQVIA OCE Customers
Linguamatics
324 Cambridge Science Park,
Cambridge, CB4 0WG,
United Kingdom
Cambridge, CB4 0WG,
United Kingdom
44 12 2365-1910
Professional Services
94
$14M
Since 2010, our global team of researchers has been studying IQVIA OCE customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased IQVIA OCE for Customer Engagement from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using IQVIA OCE for Customer Engagement include: Roche, a Switzerland based Life Sciences organisation with 112774 employees and revenues of $80.28 billion, AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Novo Nordisk, a Denmark based Life Sciences organisation with 78554 employees and revenues of $45.92 billion, Sagent Pharmaceuticals, a United States based Life Sciences organisation with 440 employees and revenues of $80.0 million, Theramex, a United Kingdom based Life Sciences organisation with 510 employees and revenues of $57.0 million and many others.
Contact us if you need a completed and verified list of companies using IQVIA OCE, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The IQVIA OCE customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | IQVIA | IQVIA OCE | Customer Engagement | 2019 | n/a |
In 2019 AstraZeneca implemented IQVIA OCE to advance its digital agenda and establish a Field of the Future for customer-facing teams. The deployment began with an initial rollout in the United States, explicitly targeting Oncology and specialized medicines to support complex account coverage and multi-disciplinary engagement models.
IQVIA OCE Orchestrated Customer Engagement platform was configured to provide a unified, continuously updated account view and orchestration capabilities for multiple field users who call on the same large accounts. Core functional capabilities implemented included customer engagement orchestration, shared interaction timelines, decision support driven by machine learning algorithms, and advanced analytics for customer insights and engagement planning.
The implementation is powered by IQVIA CORE and was positioned to unify and coordinate AstraZeneca sales, in-house marketing and medical functions, reducing operational and information silos across teams. The Customer Engagement solution enabled collaboration workflows that allow users in sales, medical and marketing roles to share consistent interaction records and align outreach strategies for complex accounts.
Governance and process changes focused on information sharing and role-based access to the shared account view, enabling coordinated engagement and improved decision making. Reported platform benefits included enhanced customer insights, improved decision making and optimized individual engagements, all delivered through the IQVIA OCE Customer Engagement framework.
|
 |
FORUM Pharmaceuticals | Life Sciences | 60 | $10M | United States | IQVIA | IQVIA OCE | Customer Engagement | 2015 | n/a |
In 2015, FORUM Pharmaceuticals implemented IQVIA OCE, IQVIA Orchestrated Customer Engagement, as its Customer Engagement solution on the company website. The deployment was site-centric and focused on web-based orchestration and digital engagement workflows sized to a small life sciences commercial organization. The implementation emphasized online content delivery, visitor interaction tracking, and audience segmentation capabilities that align with Orchestrated Customer Engagement functionality.
IQVIA Orchestrated Customer Engagement was embedded into the website to execute engagement logic, personalize on-site content, and capture interaction events for commercial and marketing follow up, with configuration and campaign management owned by the marketing and commercial teams. Operational coverage is limited to the corporate website and commercial functions, enabling campaign orchestration, sequenced engagement flows, and engagement reporting as core operational capabilities. Governance was structured around centralized campaign configuration and role-based access to the IQVIA OCE instance to control messaging and content changes.
|
 |
Novo Nordisk | Life Sciences | 78554 | $45.9B | Denmark | IQVIA | IQVIA OCE | Customer Engagement | 2018 | n/a |
In 2018, Novo Nordisk selected IQVIA OCE, IQVIA’s Orchestrated Customer Engagement platform, for deployment across Novo Nordisk International Operations. The selection targeted Customer Engagement to connect marketing, sales, medical science liaisons, account management and other customer facing functions, positioning IQVIA OCE to support commercial and medical engagement workflows within Novo Nordisk.
The implementation emphasizes orchestrated customer engagement workflows and decision support features, including predictive analytics and machine learning capabilities called out by IQVIA. Configuration work focused on aligning multichannel engagement orchestration and field force coordination to commercial and medical science liaison processes.
Architecturally IQVIA OCE is built on Salesforce.com, MuleSoft, Amazon Web Services, Heroku and Box, creating an integrated stack that combines CRM, API middleware and cloud infrastructure to enable data driven engagement and optimized performance. Integrations were designed to surface analytics and content to field teams and to centralize engagement records for account management and marketing functions.
Governance and rollout were planned at the international operations level with a global rollout excluding Canada and the U.S., and with Novo Nordisk planning to switch existing platforms to IQVIA OCE in 2019 and beyond. The stated operational goals were to streamline processes, further develop customer relationships and better anticipate and respond to market changes, impacting commercial, medical and account management workflows and requiring cross functional coordination for orchestration of customer engagement.
|
 |
Roche | Life Sciences | 112774 | $80.3B | Switzerland | IQVIA | IQVIA OCE | Customer Engagement | 2018 | n/a |
In 2018, Roche deployed IQVIA OCE as part of IQVIA’s Technologies suite to strengthen Customer Engagement across its pharmaceuticals division. The rollout was established under a multi year agreement covering approximately 14,000 users across more than 100 countries. IQVIA OCE served as the principal orchestration layer for commercial engagement initiatives within Roche Pharma.
The implementation included OCE Sales, OCE Marketing, Organization Manager, Master Data Management MDM, and ePromo, configured to support coordinated field and digital activities. Functional configuration emphasized unified customer profiles, campaign orchestration, and promotional content management to align sales, marketing, medical science liaisons, and account management. The solution was positioned to better inform commercial decision making through consolidated customer engagement data.
Architecturally the suite was built on Salesforce.com with integration and middleware via Mulesoft, cloud hosting and platform services on Amazon Web Services and Heroku, and secure content storage through Box, enabling a CRM centric cloud topology. These platform relationships allowed the IQVIA OCE applications to orchestrate data flows between CRM, content, and master data domains. The integration footprint supported cross departmental workflows and real time data synchronization for the Customer Engagement portfolio.
Governance and rollout emphasized centralized data stewardship through the Master Data Management component and organizational alignment via Organization Manager, supporting a coordinated global rollout across Roche Pharma markets. The stated objectives for the IQVIA OCE deployment included driving more meaningful customer engagement and interactions, better informing commercial decisions, enhancing customer experience, strengthening relationships, and driving performance. Operational scope focused on commercial functions within Roche’s pharmaceuticals division across 100 plus markets.
|
 |
Sagent Pharmaceuticals | Life Sciences | 440 | $80M | United States | IQVIA | IQVIA OCE | Customer Engagement | 2015 | n/a |
In 2015, Sagent Pharmaceuticals implemented IQVIA OCE. The company deployed IQVIA Orchestrated Customer Engagement from the Customer Engagement category to instrument its public website and to provide a centralized layer for digital customer interactions and campaign orchestration.
The implementation emphasized web-based orchestration and digital engagement capabilities common to Customer Engagement platforms, including campaign orchestration, content delivery and personalization, audience segmentation, and workflow automation for campaign execution. IQVIA Orchestrated Customer Engagement was configured to manage web touchpoints and to control content flows and engagement logic that drive customer journeys on the site.
Operationally the deployment is focused on the website as the primary channel, enabling commercial and marketing functions to run and monitor web-driven engagement programs. The configuration supports real-time interaction capture and orchestration across web sessions, aligning digital campaign controls with the organizations customer engagement workflows.
Governance was structured around centralized campaign and content control to ensure consistent messaging and approval flows across commercial activities, using the applications orchestration and workflow capabilities common in life sciences customer engagement deployments. The narrative reflects Sagent Pharmaceuticals using IQVIA OCE to unify website engagement and to provide marketing and commercial teams with an integrated Customer Engagement platform.
|
 |
|
Life Sciences | 510 | $57M | United Kingdom | IQVIA | IQVIA OCE | Customer Engagement | 2018 | n/a |
|
Showing 1 to 6 of 6 entries
Buyer Intent: Companies Evaluating IQVIA OCE
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating IQVIA OCE. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating IQVIA OCE for Customer Engagement include:
- Merz Therapeutics, a Germany based Life Sciences organization with 480 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated |
|---|---|---|---|---|---|---|
 |
Merz Therapeutics | Life Sciences | 480 | $120M | Germany | 2026-03-11 |
FAQ - APPS RUN THE WORLD IQVIA OCE Coverage
IQVIA OCE is a Customer Engagement solution from IQVIA.
Companies worldwide use IQVIA OCE, from small firms to large enterprises across 21+ industries.
Organizations such as Roche, AstraZeneca, Novo Nordisk, Sagent Pharmaceuticals and Theramex are recorded users of
IQVIA OCE for Customer Engagement.
Companies using IQVIA OCE are most concentrated in Life Sciences, with adoption spanning over 21 industries.
Companies using IQVIA OCE are most concentrated in Switzerland, United Kingdom and Denmark, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of IQVIA OCE across Americas, EMEA, and APAC.
Companies using IQVIA OCE range from small businesses with 0-100 employees - 16.67%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 50%.
Customers of IQVIA OCE include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified IQVIA OCE customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Customer Engagement.